A Prospective, Randomized, Active-Controlled, Single-blind, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Haemostasis During Surgery in Paediatric Subjects
Phase of Trial: Phase III
Latest Information Update: 18 Nov 2019
Price : $35 *
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Registrational; Therapeutic Use
- Sponsors Grifols
- 29 Jan 2019 Status changed from not yet recruiting to recruiting.
- 12 Sep 2018 Planned initiation date changed from 30 Mar 2018 to 30 Dec 2018.
- 14 Mar 2018 New trial record